MAL2 and hepatocellular carcinoma: However, we determined that MAL2 protein expression levels are decreased in HCC, CC and RCC, displays an extremely low somatic mutation rate in human cancers and its function is more consistent with it being a tumor suppressor leaving us with a paradox.